MedPath

Hikma Pharmaceuticals USA Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

346

FDA:346

Drug Approvals

Morphine Sulfate

Approval Date
Nov 15, 2024
FDA

Midazolam

Approval Date
Mar 29, 2024
FDA

Neostigmine Methylsulfate

Approval Date
Mar 29, 2024
FDA

Dexamethasone Sodium Phosphate

Approval Date
Mar 20, 2024
FDA

Risperidone

Approval Date
Mar 19, 2024
FDA

Methylprednisolone Sodium Succinate

Approval Date
Mar 18, 2024
FDA

Methylprednisolone Sodium Succinate

Approval Date
Mar 18, 2024
FDA

Benztropine Mesylate

Approval Date
Mar 15, 2024
FDA

Digoxin

Approval Date
Mar 15, 2024
FDA

Chlorpromazine hydrochloride

Approval Date
Mar 15, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 35
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy